A Spectrofluorometric Method for Real‐Time Graft Assessment and Patient Monitoring
Source abstract
Abstract
Abstract Biomarkers are powerful clinical diagnostics and predictors of patient outcome. However, robust measurements often require time and expensive laboratory equipment, which is insufficient to track rapid changes and limits direct use in the operating room. Here, this study presents a portable spectrophotometric device for continuous real‐time measurements of fluorescent and non‐fluorescent biomarkers at the point of care. This study measures the mitochondrial damage biomarker flavin mononucleotide (FMN) in 26 extended criteria human liver grafts undergoing hypothermic oxygenated perfusion to guide clinical graft assessment. Real‐time data identified seven organs unsuitable for transplant that are discarded. The remaining grafts are transplanted and FMN values correlated with post‐transplant indicators of liver function and patient recovery. Further, this study shows how this device can be used to monitor dialysis patients by measuring creatinine in real‐time. Our approach provides a simple method to monitor biomarkers directly within biological fluids to improve organ assessment, patient care, and biomarker discovery.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Organ Transplantation Techniques and Outcomes · Liver Disease and Transplantation · Liver Disease Diagnosis and Treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Macromolecular Engineering Lab, Department of Mechanical and Process Engineering ETH Zurich Zurich 8092 Switzerland
Department of Surgery and Transplantation, Swiss Hepato‐Pancreato‐Biliary (HPB) and Transplant Center University Hospital Zurich Zurich 8091 Switzerland
Wyss Zurich Translational Center ETH Zurich and University of Zurich Zurich 8092 Switzerland
Funding
Eidgenössische Technische Hochschule Zürich
References (59)
Show source-provided references
1. 10.1007/978-1-4939-7431-310.1007/978-1-4939-7431-3 ↗
2. Aronson J. K. · Curr. Protoc. · 2017 · 76 · 1
3. 10.1038/469156a10.1038/469156a ↗
4. 10.1097/COH.0b013e32833ed17710.1097/COH.0b013e32833ed177 ↗
5. 10.1016/j.jhep.2014.07.02110.1016/j.jhep.2014.07.021 ↗
6. 10.1056/NEJM19871008317150110.1056/NEJM198710083171501 ↗
7. 10.1016/j.bjmsu.2011.08.00610.1016/j.bjmsu.2011.08.006 ↗
8. 10.1016/j.eururo.2007.10.04710.1016/j.eururo.2007.10.047 ↗
9. 10.1007/s13311-011-0050-410.1007/s13311-011-0050-4 ↗
10. 10.4155/bio.09.18510.4155/bio.09.185 ↗
11. 10.3390/s1807201010.3390/s18072010 ↗
12. 10.1002/prca.20140020210.1002/prca.201400202 ↗
13. 10.3390/transplantology202001510.3390/transplantology2020015 ↗
14. 10.1038/s41598-018-19947-110.1038/s41598-018-19947-1 ↗
15. 10.1002/cyto.a.2359710.1002/cyto.a.23597 ↗
16. 10.1097/SLA.000000000000351310.1097/SLA.0000000000003513 ↗
17. 10.1056/NEJMra150708010.1056/NEJMra1507080 ↗
18. 10.1002/lt.2569210.1002/lt.25692 ↗
19. 10.1016/j.jhep.2011.01.04010.1016/j.jhep.2011.01.040 ↗
20. 10.1007/s40472-020-00283-110.1007/s40472-020-00283-1 ↗
21. 10.1097/SLA.000000000000241910.1097/SLA.0000000000002419 ↗
22. 10.1097/SLA.0b013e318210478410.1097/SLA.0b013e3182104784 ↗
23. 10.3109/08941939.2014.93247310.3109/08941939.2014.932473 ↗
24. 10.3390/jcm903084610.3390/jcm9030846 ↗
25. 10.3390/ijms1905130210.3390/ijms19051302 ↗
26. 10.1016/j.jhep.2019.05.02910.1016/j.jhep.2019.05.029 ↗
27. 10.1016/j.ebiom.2020.10301410.1016/j.ebiom.2020.103014 ↗
28. 10.1007/s11064-013-0991-610.1007/s11064-013-0991-6 ↗
29. 10.1056/NEJMoa203153210.1056/NEJMoa2031532 ↗
30. 10.1007/s40472-018-0178-910.1007/s40472-018-0178-9 ↗
31. 10.1002/lt.2045610.1002/lt.20456 ↗
32. 10.1111/j.1600-6143.2006.01242.x10.1111/j.1600-6143.2006.01242.x ↗
33. 10.1111/j.1600-6143.2012.04195.x10.1111/j.1600-6143.2012.04195.x ↗
34. 10.1111/ajt.1468710.1111/ajt.14687 ↗
35. 10.1038/s41587-019-0374-x10.1038/s41587-019-0374-x ↗
36. Clavien P.‐A. · Nat. Biotechnol. · 2022
37. 10.1016/j.celrep.2018.04.10410.1016/j.celrep.2018.04.104 ↗
38. 10.1038/nature1390910.1038/nature13909 ↗
39. 10.1146/annurev-biochem-070511-10370010.1146/annurev-biochem-070511-103700 ↗
40. 10.3390/biomedicines902016110.3390/biomedicines9020161 ↗
41. Stepanova A. · ARS · 2019 · 31 · 608
42. 10.3390/ijms2206322410.3390/ijms22063224 ↗
43. 10.1016/j.jhep.2013.11.02310.1016/j.jhep.2013.11.023 ↗
44. 10.1111/tri.1252410.1111/tri.12524 ↗
45. 10.1111/j.1542-4758.2007.00223.x10.1111/j.1542-4758.2007.00223.x ↗
46. 10.1002/lt.2352210.1002/lt.23522 ↗
47. 10.1038/s41572-018-0022-710.1038/s41572-018-0022-7 ↗
48. Shahbaz H. · 2022
49. Gowda S. · N. Am. J. Med. Sci. · 2010 · 2 · 4
50. 10.1097/00041552-199511000-0000910.1097/00041552-199511000-00009 ↗
51. 10.1007/s11255-022-03301-610.1007/s11255-022-03301-6 ↗
52. 10.1159/00018593810.1159/000185938 ↗
53. 10.1038/sj.ki.500021610.1038/sj.ki.5000216 ↗
54. 10.1097/00007890-200105270-0001210.1097/00007890-200105270-00012 ↗
55. 10.5858/2005-129-297-CMSOTA10.5858/2005-129-297-CMSOTA ↗
56. 10.1016/j.aca.2020.08.01710.1016/j.aca.2020.08.017 ↗
57. 10.1016/j.jchromb.2019.03.00110.1016/j.jchromb.2019.03.001 ↗
58. 10.1039/D0PY00403K10.1039/D0PY00403K ↗
59. 10.1016/j.ijsu.2020.04.05710.1016/j.ijsu.2020.04.057 ↗